News

Bristol Myers Squibb and Bain Capital Form New Immunology Company
The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...
Bristol Myers, Bain Capital form new company to develop immunology drugs
Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...
Bristol Myers, Bain Capital form a new biopharmaceutical company
Bristol Myers Squibb and Bain Capital launch a new biopharma firm focused on autoimmune disease treatments, starting with 5 ...
Contract Pharma20h
BMS, Bain Capital Form New Independent Biopharma Company
Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...
PE Hub1d
Bain Capital and Bristol Myers Squibb form new biopharma company
Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...
The South African on MSN4h
State capture-implicated Bain & Company shuts down SA operations
Bain & Company, which was brought to South Africa by former President Jacob Zuma, scored a R187m contract to restructure SARS ...
Pharmaceutical Technology on MSN1d
BMS and Bain Capital forge $300m immunology spinoff
The biopharma spinoff will advance the development of its five investigational therapies designed to treat autoimmune disease.
Harvard Business Review1d
The 30 Elements of Consumer Value: A Hierarchy
Three decades of experience doing consumer research and observation for corporate clients led the authors—all with Bain & Company—to identify 30 “elements of value.” ...
Wall Street Journal7d
Bain Capital Specialty Finance Inc. - The Wall Street Journal
News Bain Capital Specialty Finance Inc. Significant News Only 12 hours ago Press Release Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Second Quarter Ended June 30, 2025 ...